Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 27  •  04:00PM ET
2.31
Dollar change
-0.06
Percentage change
-2.53
%
May 26, 4:05 AMFDA De Novo clearance for DeepView AI system drives 20% MDAI premarket surge
Index
-
P/E
-
EPS (ttm)
-0.53
Insider Own
15.53%
Shs Outstand
31.82M
Perf Week
-2.53%
Market Cap
73.51M
Forward P/E
-
EPS next Y
-0.54
Insider Trans
0.00%
Shs Float
26.88M
Perf Month
17.86%
Enterprise Value
71.80M
PEG
-
EPS next Q
-0.14
Inst Own
7.57%
Perf Quarter
62.68%
Income
-14.29M
P/S
4.40
EPS this Y
-76.70%
Inst Trans
-8.70%
Perf Half Y
61.54%
Sales
16.70M
P/B
-
EPS next Y
-5.12%
ROA
-74.32%
Perf YTD
62.68%
Book/sh
-0.28
P/C
6.31
EPS next 5Y
-26.84%
ROE
-
52W High
3.21 -28.04%
Perf Year
57.14%
Cash/sh
0.37
P/FCF
-
EPS past 3/5Y
-8.80% -
ROIC
-
52W Low
1.18 95.76%
Perf 3Y
-77.68%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-8.16% -
Gross Margin
44.73%
Volatility
13.90% 10.16%
Perf 5Y
-76.01%
Dividend TTM
-
EV/Sales
4.30
EPS Y/Y TTM
-0.39%
Oper. Margin
-59.39%
ATR (14)
0.23
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.71
Sales Y/Y TTM
-44.27%
Profit Margin
-85.58%
RSI (14)
54.05
Dividend Gr. 3/5Y
- -
Current Ratio
0.75
EPS Q/Q
-196.41%
SMA20
1.36%
Beta
1.18
Payout
-
Debt/Eq
-
Sales Q/Q
-40.50%
SMA50
20.60%
Rel Volume
1.54
Prev Close
2.37
Employees
65
LT Debt/Eq
-
SMA200
26.03%
Avg Volume
938.85K
Price
2.31
IPO
Apr 06, 2021
Option/Short
No / Yes
Trades
Volume
1,421,850
Change
-2.53%
Date Action Analyst Rating Change Price Target Change
Jan-23-24Initiated BTIG Research Buy $4
May-26-26 07:00AM
May-13-26 01:00AM
May-12-26 04:10PM
May-11-26 09:23AM
Apr-30-26 08:30AM
04:15PM Loading…
Apr-28-26 04:15PM
Apr-22-26 08:30AM
Apr-20-26 04:15PM
Apr-09-26 08:30AM
Apr-08-26 08:30AM
Mar-26-26 10:09AM
Mar-24-26 11:00PM
04:25PM
Mar-23-26 09:22AM
Mar-18-26 04:05PM
08:30AM Loading…
Mar-10-26 08:30AM
Feb-10-26 08:30AM
Feb-02-26 08:30AM
Dec-11-25 06:00AM
Nov-19-25 08:00AM
Nov-12-25 12:03AM
Nov-11-25 04:00PM
Nov-10-25 07:22AM
Oct-28-25 04:00PM
10:06AM
Oct-23-25 08:30AM
Sep-19-25 08:00AM
Sep-10-25 08:00AM
Aug-26-25 08:54AM
Aug-13-25 03:13AM
04:00PM Loading…
Aug-12-25 04:00PM
Aug-11-25 09:42AM
Jul-30-25 08:00AM
Jul-29-25 03:01PM
Jul-12-25 06:45AM
Jul-07-25 09:30AM
Jun-30-25 08:00AM
Jun-20-25 09:11AM
Jun-10-25 08:00AM
May-30-25 08:00AM
May-29-25 08:00AM
May-27-25 08:00AM
May-20-25 08:00AM
May-13-25 04:05PM
May-02-25 04:00PM
Apr-30-25 04:00PM
Apr-16-25 08:45AM
Apr-02-25 11:09AM
Mar-31-25 10:06AM
Mar-30-25 12:22PM
Mar-27-25 07:06PM
04:55PM
Mar-24-25 07:30AM
Mar-20-25 04:00PM
Mar-17-25 07:00AM
Mar-06-25 10:36AM
Feb-28-25 10:34AM
08:00AM
Feb-18-25 07:00AM
Feb-11-25 09:00AM
Feb-07-25 08:21AM
Jan-28-25 09:44AM
Jan-22-25 08:00AM
Dec-31-24 08:00AM
Dec-23-24 08:00AM
Dec-13-24 11:53AM
Dec-12-24 08:00AM
Dec-09-24 08:00AM
Dec-04-24 09:15AM
Dec-02-24 08:39AM
Nov-26-24 10:17AM
Nov-21-24 08:00AM
Nov-19-24 08:00AM
Nov-06-24 04:05PM
08:00AM
Oct-30-24 08:00AM
Oct-23-24 04:50PM
Oct-14-24 04:05PM
Oct-03-24 08:00AM
Sep-24-24 08:00AM
Sep-17-24 08:00AM
Sep-10-24 08:00AM
Sep-05-24 08:00AM
Aug-28-24 04:30PM
Aug-27-24 08:00AM
Aug-19-24 08:00AM
Aug-12-24 04:05PM
Jul-31-24 08:00AM
Jul-29-24 09:00AM
Jul-24-24 08:00AM
Jul-23-24 08:00AM
Jul-15-24 08:00AM
Jul-08-24 08:00AM
Jul-03-24 08:00AM
Jul-02-24 08:00AM
Jul-01-24 08:00AM
Jun-27-24 08:00AM
Jun-24-24 08:00AM
Jun-17-24 04:15PM
Jun-12-24 08:02AM
Spectral AI, Inc. is a predictive artificial intelligence company. It focuses on medical diagnostics for accurate treatment decisions in wound care for burn, DFU, and future clinical applications. Its DeepView platform is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company was founded by John Michael DiMaio and Wen Sheng Fan on November 17, 2020 and is headquartered in Dallas, TX.
Founder & ChairmanDr. John Michael DiMaio M.D.
CEO & Corporate SecretaryMr. Vincent Stanley Capone Esq.
Chief Operating OfficerMr. Stanley Micek
Head of Regulatory Affairs & Clinical TrialsMs. Allison Kumar
General ManagerMr. Louis Percoco
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Erich Spangenberg; ELS 1960 FaFormer DirectorJul 21 '25Proposed Sale2.51736,1311,847,689Jul 21 06:07 AM